Effect of cell culture medium components on color of formulated monoclonal antibody drug substance
As the industry moves toward subcutaneous delivery as a preferred route of drug administration, high drug substance concentrations are becoming the norm for monoclonal antibodies. At such high concentrations, the drug substance may display a more intense color than at the historically lower concentr...
Gespeichert in:
Veröffentlicht in: | Biotechnology progress 2013-09, Vol.29 (5), p.1270-1277 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1277 |
---|---|
container_issue | 5 |
container_start_page | 1270 |
container_title | Biotechnology progress |
container_volume | 29 |
creator | Vijayasankaran, Natarajan Varma, Sharat Yang, Yi Mun, Melissa Arevalo, Silvana Gawlitzek, Martin Swartz, Trevor Lim, Amy Li, Feng Zhang, Boyan Meier, Steve Kiss, Robert |
description | As the industry moves toward subcutaneous delivery as a preferred route of drug administration, high drug substance concentrations are becoming the norm for monoclonal antibodies. At such high concentrations, the drug substance may display a more intense color than at the historically lower concentrations. The effect of process conditions and/or changes on color is more readily observed in the higher color, high concentration formulations. Since color is a product quality attribute that needs to be controlled, it is useful to study the impact of process conditions and/or modifications on color. This manuscript summarizes cell culture experiments and reports on findings regarding the effect of various media components that contribute to drug substance color for a specific monoclonal antibody. In this work, lower drug substance color was achieved via optimization of the cell culture medium. Specifically, lowering the concentrations of B‐vitamins in the cell culture medium has the effect of reducing color intensity by as much as 25%. In addition, decreasing concentration of iron was also directly correlated color intensity decrease of as much as 37%. It was also shown that the color of the drug substance directly correlates with increased acidic variants, especially when increased iron levels cause increased color. Potential mechanisms that could lead to antibody coloration are briefly discussed. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 29:1270–1277, 2013 |
doi_str_mv | 10.1002/btpr.1772 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1503550534</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1503550534</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4002-abe94ae77e7d107fee9b560752c649079826405d7f1c8fa77f54224e02bbdd9f3</originalsourceid><addsrcrecordid>eNp1kE1v1DAQhi0EokvhwB9APsIh7cQfcXKkq1KQ-oGgiKPlOGMUcOLFH4L99yTapbeeRiM97zuah5DXNZzVAOy8z7t4VivFnpBNLRlUDXD-lGxaJZtKdbw9IS9S-gkALTTsOTlhvAUhGrYh_aVzaDMNjlr0ntric4lIJxzGMlEbpl2Ycc6JhnnZfIgr6kKcijcZBzqFOVgfZuOpmfPYh2FPh1h-0FT6lM1s8SV55oxP-Oo4T8m3D5f324_V9d3Vp-3768qK5YnK9NgJg0qhGmpQDrHrZQNKMtuIDlTXskaAHJSrbeuMUk4KxgQC6_th6Bw_JW8PvbsYfhdMWU9jWp8yM4aSdC2BSwmSiwV9d0BtDClFdHoXx8nEva5Br0r1qlSvShf2zbG29IuVB_K_wwU4PwB_Ro_7x5v0xf3nL8fK6pAYU8a_DwkTf-lGcSX199srDV8veLdVN8uhf-l8kPU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1503550534</pqid></control><display><type>article</type><title>Effect of cell culture medium components on color of formulated monoclonal antibody drug substance</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Vijayasankaran, Natarajan ; Varma, Sharat ; Yang, Yi ; Mun, Melissa ; Arevalo, Silvana ; Gawlitzek, Martin ; Swartz, Trevor ; Lim, Amy ; Li, Feng ; Zhang, Boyan ; Meier, Steve ; Kiss, Robert</creator><creatorcontrib>Vijayasankaran, Natarajan ; Varma, Sharat ; Yang, Yi ; Mun, Melissa ; Arevalo, Silvana ; Gawlitzek, Martin ; Swartz, Trevor ; Lim, Amy ; Li, Feng ; Zhang, Boyan ; Meier, Steve ; Kiss, Robert</creatorcontrib><description>As the industry moves toward subcutaneous delivery as a preferred route of drug administration, high drug substance concentrations are becoming the norm for monoclonal antibodies. At such high concentrations, the drug substance may display a more intense color than at the historically lower concentrations. The effect of process conditions and/or changes on color is more readily observed in the higher color, high concentration formulations. Since color is a product quality attribute that needs to be controlled, it is useful to study the impact of process conditions and/or modifications on color. This manuscript summarizes cell culture experiments and reports on findings regarding the effect of various media components that contribute to drug substance color for a specific monoclonal antibody. In this work, lower drug substance color was achieved via optimization of the cell culture medium. Specifically, lowering the concentrations of B‐vitamins in the cell culture medium has the effect of reducing color intensity by as much as 25%. In addition, decreasing concentration of iron was also directly correlated color intensity decrease of as much as 37%. It was also shown that the color of the drug substance directly correlates with increased acidic variants, especially when increased iron levels cause increased color. Potential mechanisms that could lead to antibody coloration are briefly discussed. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 29:1270–1277, 2013</description><identifier>ISSN: 8756-7938</identifier><identifier>EISSN: 1520-6033</identifier><identifier>DOI: 10.1002/btpr.1772</identifier><identifier>PMID: 23804462</identifier><language>eng</language><publisher>United States: Blackwell Publishing Ltd</publisher><subject>Animals ; Antibodies, Monoclonal - chemistry ; antibody ; B12 ; Bioreactors ; cell culture ; Cell Culture Techniques ; CHO ; CHO Cells ; Chromatography, Ion Exchange ; Color ; Cricetulus ; Culture Media - chemistry ; fed-batch ; ferrous sulfate ; Folic Acid - pharmacology ; iron ; Iron - pharmacology ; medium optimization ; protein color ; Pyridoxal - pharmacology ; Pyridoxine - pharmacology ; Riboflavin - pharmacology ; Vitamin B 12 - pharmacology ; Vitamin B Complex - pharmacology</subject><ispartof>Biotechnology progress, 2013-09, Vol.29 (5), p.1270-1277</ispartof><rights>2013 American Institute of Chemical Engineers</rights><rights>2013 American Institute of Chemical Engineers.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4002-abe94ae77e7d107fee9b560752c649079826405d7f1c8fa77f54224e02bbdd9f3</citedby><cites>FETCH-LOGICAL-c4002-abe94ae77e7d107fee9b560752c649079826405d7f1c8fa77f54224e02bbdd9f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fbtpr.1772$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fbtpr.1772$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23804462$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Vijayasankaran, Natarajan</creatorcontrib><creatorcontrib>Varma, Sharat</creatorcontrib><creatorcontrib>Yang, Yi</creatorcontrib><creatorcontrib>Mun, Melissa</creatorcontrib><creatorcontrib>Arevalo, Silvana</creatorcontrib><creatorcontrib>Gawlitzek, Martin</creatorcontrib><creatorcontrib>Swartz, Trevor</creatorcontrib><creatorcontrib>Lim, Amy</creatorcontrib><creatorcontrib>Li, Feng</creatorcontrib><creatorcontrib>Zhang, Boyan</creatorcontrib><creatorcontrib>Meier, Steve</creatorcontrib><creatorcontrib>Kiss, Robert</creatorcontrib><title>Effect of cell culture medium components on color of formulated monoclonal antibody drug substance</title><title>Biotechnology progress</title><addtitle>Biotechnol Progress</addtitle><description>As the industry moves toward subcutaneous delivery as a preferred route of drug administration, high drug substance concentrations are becoming the norm for monoclonal antibodies. At such high concentrations, the drug substance may display a more intense color than at the historically lower concentrations. The effect of process conditions and/or changes on color is more readily observed in the higher color, high concentration formulations. Since color is a product quality attribute that needs to be controlled, it is useful to study the impact of process conditions and/or modifications on color. This manuscript summarizes cell culture experiments and reports on findings regarding the effect of various media components that contribute to drug substance color for a specific monoclonal antibody. In this work, lower drug substance color was achieved via optimization of the cell culture medium. Specifically, lowering the concentrations of B‐vitamins in the cell culture medium has the effect of reducing color intensity by as much as 25%. In addition, decreasing concentration of iron was also directly correlated color intensity decrease of as much as 37%. It was also shown that the color of the drug substance directly correlates with increased acidic variants, especially when increased iron levels cause increased color. Potential mechanisms that could lead to antibody coloration are briefly discussed. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 29:1270–1277, 2013</description><subject>Animals</subject><subject>Antibodies, Monoclonal - chemistry</subject><subject>antibody</subject><subject>B12</subject><subject>Bioreactors</subject><subject>cell culture</subject><subject>Cell Culture Techniques</subject><subject>CHO</subject><subject>CHO Cells</subject><subject>Chromatography, Ion Exchange</subject><subject>Color</subject><subject>Cricetulus</subject><subject>Culture Media - chemistry</subject><subject>fed-batch</subject><subject>ferrous sulfate</subject><subject>Folic Acid - pharmacology</subject><subject>iron</subject><subject>Iron - pharmacology</subject><subject>medium optimization</subject><subject>protein color</subject><subject>Pyridoxal - pharmacology</subject><subject>Pyridoxine - pharmacology</subject><subject>Riboflavin - pharmacology</subject><subject>Vitamin B 12 - pharmacology</subject><subject>Vitamin B Complex - pharmacology</subject><issn>8756-7938</issn><issn>1520-6033</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kE1v1DAQhi0EokvhwB9APsIh7cQfcXKkq1KQ-oGgiKPlOGMUcOLFH4L99yTapbeeRiM97zuah5DXNZzVAOy8z7t4VivFnpBNLRlUDXD-lGxaJZtKdbw9IS9S-gkALTTsOTlhvAUhGrYh_aVzaDMNjlr0ntric4lIJxzGMlEbpl2Ycc6JhnnZfIgr6kKcijcZBzqFOVgfZuOpmfPYh2FPh1h-0FT6lM1s8SV55oxP-Oo4T8m3D5f324_V9d3Vp-3768qK5YnK9NgJg0qhGmpQDrHrZQNKMtuIDlTXskaAHJSrbeuMUk4KxgQC6_th6Bw_JW8PvbsYfhdMWU9jWp8yM4aSdC2BSwmSiwV9d0BtDClFdHoXx8nEva5Br0r1qlSvShf2zbG29IuVB_K_wwU4PwB_Ro_7x5v0xf3nL8fK6pAYU8a_DwkTf-lGcSX199srDV8veLdVN8uhf-l8kPU</recordid><startdate>201309</startdate><enddate>201309</enddate><creator>Vijayasankaran, Natarajan</creator><creator>Varma, Sharat</creator><creator>Yang, Yi</creator><creator>Mun, Melissa</creator><creator>Arevalo, Silvana</creator><creator>Gawlitzek, Martin</creator><creator>Swartz, Trevor</creator><creator>Lim, Amy</creator><creator>Li, Feng</creator><creator>Zhang, Boyan</creator><creator>Meier, Steve</creator><creator>Kiss, Robert</creator><general>Blackwell Publishing Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201309</creationdate><title>Effect of cell culture medium components on color of formulated monoclonal antibody drug substance</title><author>Vijayasankaran, Natarajan ; Varma, Sharat ; Yang, Yi ; Mun, Melissa ; Arevalo, Silvana ; Gawlitzek, Martin ; Swartz, Trevor ; Lim, Amy ; Li, Feng ; Zhang, Boyan ; Meier, Steve ; Kiss, Robert</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4002-abe94ae77e7d107fee9b560752c649079826405d7f1c8fa77f54224e02bbdd9f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Animals</topic><topic>Antibodies, Monoclonal - chemistry</topic><topic>antibody</topic><topic>B12</topic><topic>Bioreactors</topic><topic>cell culture</topic><topic>Cell Culture Techniques</topic><topic>CHO</topic><topic>CHO Cells</topic><topic>Chromatography, Ion Exchange</topic><topic>Color</topic><topic>Cricetulus</topic><topic>Culture Media - chemistry</topic><topic>fed-batch</topic><topic>ferrous sulfate</topic><topic>Folic Acid - pharmacology</topic><topic>iron</topic><topic>Iron - pharmacology</topic><topic>medium optimization</topic><topic>protein color</topic><topic>Pyridoxal - pharmacology</topic><topic>Pyridoxine - pharmacology</topic><topic>Riboflavin - pharmacology</topic><topic>Vitamin B 12 - pharmacology</topic><topic>Vitamin B Complex - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Vijayasankaran, Natarajan</creatorcontrib><creatorcontrib>Varma, Sharat</creatorcontrib><creatorcontrib>Yang, Yi</creatorcontrib><creatorcontrib>Mun, Melissa</creatorcontrib><creatorcontrib>Arevalo, Silvana</creatorcontrib><creatorcontrib>Gawlitzek, Martin</creatorcontrib><creatorcontrib>Swartz, Trevor</creatorcontrib><creatorcontrib>Lim, Amy</creatorcontrib><creatorcontrib>Li, Feng</creatorcontrib><creatorcontrib>Zhang, Boyan</creatorcontrib><creatorcontrib>Meier, Steve</creatorcontrib><creatorcontrib>Kiss, Robert</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Biotechnology progress</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Vijayasankaran, Natarajan</au><au>Varma, Sharat</au><au>Yang, Yi</au><au>Mun, Melissa</au><au>Arevalo, Silvana</au><au>Gawlitzek, Martin</au><au>Swartz, Trevor</au><au>Lim, Amy</au><au>Li, Feng</au><au>Zhang, Boyan</au><au>Meier, Steve</au><au>Kiss, Robert</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of cell culture medium components on color of formulated monoclonal antibody drug substance</atitle><jtitle>Biotechnology progress</jtitle><addtitle>Biotechnol Progress</addtitle><date>2013-09</date><risdate>2013</risdate><volume>29</volume><issue>5</issue><spage>1270</spage><epage>1277</epage><pages>1270-1277</pages><issn>8756-7938</issn><eissn>1520-6033</eissn><abstract>As the industry moves toward subcutaneous delivery as a preferred route of drug administration, high drug substance concentrations are becoming the norm for monoclonal antibodies. At such high concentrations, the drug substance may display a more intense color than at the historically lower concentrations. The effect of process conditions and/or changes on color is more readily observed in the higher color, high concentration formulations. Since color is a product quality attribute that needs to be controlled, it is useful to study the impact of process conditions and/or modifications on color. This manuscript summarizes cell culture experiments and reports on findings regarding the effect of various media components that contribute to drug substance color for a specific monoclonal antibody. In this work, lower drug substance color was achieved via optimization of the cell culture medium. Specifically, lowering the concentrations of B‐vitamins in the cell culture medium has the effect of reducing color intensity by as much as 25%. In addition, decreasing concentration of iron was also directly correlated color intensity decrease of as much as 37%. It was also shown that the color of the drug substance directly correlates with increased acidic variants, especially when increased iron levels cause increased color. Potential mechanisms that could lead to antibody coloration are briefly discussed. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 29:1270–1277, 2013</abstract><cop>United States</cop><pub>Blackwell Publishing Ltd</pub><pmid>23804462</pmid><doi>10.1002/btpr.1772</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 8756-7938 |
ispartof | Biotechnology progress, 2013-09, Vol.29 (5), p.1270-1277 |
issn | 8756-7938 1520-6033 |
language | eng |
recordid | cdi_proquest_miscellaneous_1503550534 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
subjects | Animals Antibodies, Monoclonal - chemistry antibody B12 Bioreactors cell culture Cell Culture Techniques CHO CHO Cells Chromatography, Ion Exchange Color Cricetulus Culture Media - chemistry fed-batch ferrous sulfate Folic Acid - pharmacology iron Iron - pharmacology medium optimization protein color Pyridoxal - pharmacology Pyridoxine - pharmacology Riboflavin - pharmacology Vitamin B 12 - pharmacology Vitamin B Complex - pharmacology |
title | Effect of cell culture medium components on color of formulated monoclonal antibody drug substance |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T17%3A58%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20cell%20culture%20medium%20components%20on%20color%20of%20formulated%20monoclonal%20antibody%20drug%20substance&rft.jtitle=Biotechnology%20progress&rft.au=Vijayasankaran,%20Natarajan&rft.date=2013-09&rft.volume=29&rft.issue=5&rft.spage=1270&rft.epage=1277&rft.pages=1270-1277&rft.issn=8756-7938&rft.eissn=1520-6033&rft_id=info:doi/10.1002/btpr.1772&rft_dat=%3Cproquest_cross%3E1503550534%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1503550534&rft_id=info:pmid/23804462&rfr_iscdi=true |